Objective-Obesity associates with increased numbers of inflammatory cells in adipose tissue (AT), including T cells, but the mechanism of T-cell recruitment remains unknown. This study tested the hypothesis that the chemokine (C-X-C motif) receptor 3 (CXCR3) participates in T-cell accumulation in AT of obese mice and thus in the regulation of local inflammation and systemic metabolism. Approach and Results-Obese wild-type mice exhibited higher mRNA expression of CXCR3 in periepididymal AT-derived stromal vascular cells compared with lean mice. We evaluated the function of CXCR3 in AT inflammation in vivo using CXCR3-deficient and wild-type control mice that consumed a high-fat diet. Periepididymal AT from obese CXCR3deficient mice contained fewer T cells than obese controls after 8 and 16 weeks on high-fat diet, as assessed by flow cytometry. Obese CXCR3-deficient mice had greater glucose tolerance than obese controls after 8 weeks, but not after 16 weeks. CXCR3-deficient mice fed high-fat diet had reduced mRNA expression of proinflammatory mediators, such as monocyte chemoattractant protein-1 and regulated on activation, normal T cell expressed and secreted, and antiinflammatory genes, such as Foxp3, IL-10, and arginase-1 in periepididymal AT, compared with obese controls. Conclusions-These results demonstrate that CXCR3 contributes to T-cell accumulation in periepididymal AT of obese mice. Our results also suggest that CXCR3 regulates the accumulation of distinct subsets of T cells and that the ratio between these functional subsets across time likely modulates local inflammation and systemic metabolism. (Arterioscler Thromb Vasc Biol. 2014;34:1374-1381.)
D uring obesity, adipose tissue (AT) accumulates inflammatory cells, including macrophages 1,2 and T cells, [3] [4] [5] [6] which interact with endothelial cells and adipocytes in a local inflammatory network. This cellular cross talk augments local production of multiple chemokines and cytokines, such as monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-α, key elements in maintaining and propagating the inflammatory response in AT. 7, 8 Various studies have examined the mechanisms of macrophage accumulation in AT of obese mice. Production of large amounts of MCP-1 by adipocytes in culture and by fat from obese mice suggested that this chemokine participates in the increased local macrophage traffic. Indeed, obese animals with deficiency of MCP-1 or its receptor, chemokine (C-C motif) receptor 2 or CCR2, have fewer macrophages in AT, less local inflammation, and improved insulin sensitivity compared with obese controls. 9, 10 T lymphocytes also accumulate in AT of obese mice. We and others have shown increased T-cell numbers in AT from obese mice, relative to lean controls. 3, 4 Nishimura et al 6 demonstrated that immunologic and genetic depletion of CD8 + T cells lowered macrophage accumulation and AT inflammation and improved systemic insulin resistance. Interferon-γ (IFN-γ), a prototypical cytokine of the Th1 subpopulation and an established orchestrator of the inflammatory response in atherosclerosis and other immune conditions, regulates fat inflammation, 4 suggesting that adaptive immunity participates in the pathophysiology of obesity.
The exact mechanism of lymphocyte accumulation in AT remains unknown. Increased expression of regulated on activation, normal T cell expressed and secreted (RANTES) and its receptor (chemokine [C-C motif] receptor 5 or CCR5) in AT of obese mice and humans suggests that this duo participates in local T-cell migration, 3 a conjecture not yet supported by definitive evidence. Moreover, RANTES recruits not only T cells but also dendritic cells, natural killer cells, mast cells, eosinophils, and basophils to sites of inflammation and infection. 11 In contrast to the broad specificity of RANTES, the CXCR3 chemokine ligands-monokine induced by IFNγ (MIG), IFN-γ-inducible protein 10 (IP-10), and IFNinducible T-cell α chemoattractant-selectively induce chemoattraction of T cells. 12 Overexpression of CXCR3 and its ligands occurs in a wide array of infectious and inflammatory diseases, including atherosclerosis. 13 Indeed, apolipoprotein E-deficient mice with deletion of either CXCR3 or IP-10 have significantly less atherosclerosis than do control apolipoprotein E-deficient mice. 14, 15 Treatment with a CXCR3 antagonist (NBI-74330) mitigates plaque development in association with reduced accumulation of effector T cells and macrophages in lesions of low-density lipoprotein receptor-deficient mice. 16 Recently, we showed that the adipocyte-derived mediator adiponectin, which diminishes in the plasma of obese subjects, inhibits the production of CXCR3 ligands by macrophages and reduces T-cell accumulation in atheromata, suggesting a link between hypoadiponectinemia and T-cell accumulation via CXCR3. 17 These observations led us to test the hypothesis that CXCR3 participates in T-cell accumulation in AT of obese animals. Our results unveil CXCR3 as a crucial player in this process, demonstrating that it regulates local inflammation and affects systemic metabolic pathways that operate in obesity. Periepididymal AT-derived stromal vascular cells (SVCs) from obese C57BL6 mice had significantly higher levels of CXCR3 mRNA than SVCs from lean controls after 8 weeks of high-fat diet (HFD) or low-fat diet, respectively. Levels of mRNAs encoding the T-cell chemoattractants and the CXCR3 ligands IP-10 and MIG did not differ between the lean and obese animal groups at this time point ( Figure 1 ).
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Obese CXCR3-Deficient Mice Accumulate Fewer T Cells in Periepididymal AT Than Obese Wild-Type Mice
CXCR3-deficient mice and C57BL6 controls began consuming HFD at 8 weeks of age. With the exception of the first week of HFD feeding, body weights between the 2 groups did not differ ( Figure 2 ). CXCR3-deficient mice and controls showed no consistent differences in VO 2 , VCO 2 production, or respiratory exchange ratio (RER) before or 4 weeks after the initiation of HFD ( Figure I in the online-only Data Supplement). Physical activity was lower, and a small but statistically significant decrease occurred in food intake among the CXCR3-deficient mice compared with controls on HFD.
After 8 weeks of HFD, both groups of mice had similar mean body weights ( Figure 2 ) but different periepididymal fat weights (not shown). The number of SVCs isolated from the periepididymal AT of obese CXCR3-deficient mice compared with respective controls after 8 weeks of HFD did not differ: 2.41×10 6 (±1.4×10 6 ) SVCs and 2.76×10 6 (±1.2×10 6 ) SVCs, respectively (P=0.5; n=11-13 in each group). This lack of significant difference persisted even when the cell count was adjusted for body weight or the amount of fat used in the experiment (not shown).
Obese CXCR3-deficient animals contained fewer CD3 + T lymphocytes in their periepididymal AT (represented as % of AT-derived SVCs; Figure 3 ) compared with obese control mice (2.3±0.9 versus 3.3±0.5; P<0.01), as assessed by flow cytometry. Both CD4 + and CD8 + T-cell subsets also decreased in the same AT depot of obese CXCR3-deficient mice compared with obese wild-type counterparts (1.5±1 versus 2.6±0.7; P<0.02 and 0.8±0.3 versus 1.9±0.4; P<0.001, respectively; Figure 3 ). Proportions of B220 + B cells, F4/80 + macrophages, and CD11c + dendritic cells did not differ between the 2 groups ( Figure 3 ). Consistent with the flow cytometry results, quantitative immunohistochemistry also showed fewer CD3 + T cells in periepididymal AT from obese CXCR3-deficient mice compared with obese controls (Figure 4 ). Complete and differential blood counts did not reveal any difference in leukocyte subsets between obese CXCR3-deficient mice and obese wild-type controls in peripheral blood ( Table II in Both groups had similar mean body weight ( Figure 2 ) and periepididymal fat weight (not shown) after 16 weeks of HFD. CXCR3-deficient mice yielded significantly fewer AT-derived SVCs compared with controls: 3.43×10 6 (±3.4×10 5 ) SVCs and 5.30×10 6 (±1.7×10 6 ) SVCs, respectively (P=0.045; n=5-6 in each group). This difference persisted after adjustment of cell count for body weight but diminished after correction of the cell count for the weight of fat used in the experiment (not shown).
Similar to the results at the 8-week time point, AT from 16-week HFD-fed CXCR3-deficient mice had significantly fewer CD3 + T cells (7±0.9 versus 13±2.4; P<0.01), including both subsets-CD4 + (4±0.3 versus 10±3.5; P<0.02) and CD8 + (3.4±0.4 versus 8.9±1.8; P<0.001)-compared with control mice on the same diet ( Figure 5 ). Fat of CXCR3deficient mice had fewer CD25 + cells (panel not shown), representing both stimulated T cells and T regulatory cells (Tregs), than control mice (3.5±0.44 versus 4.4±0.58; P=0.02). AT from CXCR3-deficient mice had more F4/80 + macrophages than did control mice at the same time point ( Figure 5 ). The proportion of cells positive for CD11c or major histocompatibility complex class II (MHC II) did not differ between the 2 groups.
When consuming a low-fat diet, the body weight of CXCR3-deficient and wild-type mice showed a small yet statistically significant difference up to 9 weeks (not shown). At the time of harvesting, after ≈20 weeks of low-fat diet, the body weights of the CXCR3-deficient and control groups did not differ, although the periepididymal fat weighed less in the CXCR3-deficient mice than in controls (not shown).
Obese CXCR3-Deficient Mice Exhibit Decreased Expression of Inflammation-Related Genes in Periepididymal AT Compared With Obese Wild-Type Mice
CXCR3 deficiency led to a decrease in expression of several genes related to inflammation. After 8 weeks of HFD, obese CXCR3-deficient mice exhibited lower mRNA expression of chemokines such as MCP-1 and RANTES in AT compared with their wild-type counterparts ( Figure 6A ). Compared with controls, CXCR3-deficient mice also had lower levels of interleukin-10 (IL-10) ( Figure 6A ), a cytokine with anti-inflammatory functions. Tregs and M2 macrophages can elaborate IL-10 in several inflammatory conditions and seem to exert a metabolic protective effect in obesity. This finding prompted us to measure mRNA levels of the Treg marker Foxp3 (a forkhead family transcription factor) and arginase-1, one of the signature products of M2 macrophages in mice. The expression of these markers did not differ significantly between CXCR3-deficient mice and wild-type controls after 8 weeks of HFD ( Figure 6A ). After 16 weeks of HFD, CXCR3-deficient mice had significantly reduced expression of IL-10, Foxp3, and arginase-1 mRNAs in periepididymal AT compared with controls ( Figure 6B ). IFN-γ, a signature of T-helper 1 cells, showed a trend toward decreased mRNA expression at both 8 weeks and 16 weeks of HFD, but the differences did not reach statistical significance ( Figure 6 ). The mRNA expression levels of tumor necrosis factor-α, interleukin-6, IP-10, MIG, and MHC II did not differ between the CXCR3-deficient and control groups at both time points (not shown).
In agreement with the reduced mRNA expression of Foxp3 in the periepididymal fat of CXCR3-deficient mice compared with controls after 16 weeks of diet, immunohistochemistry also showed significantly fewer Foxp3-positive cells in the AT of CXCR3-deficient animals (Figure 7) .
Obese CXCR3-deficient mice exhibit improved glucose tolerance and decreased plasma levels of leptin and total cholesterol compared with obese wild-type mice.
Despite having comparable body weights, CXCR3deficient mice had greater glucose tolerance in response to Figure 4 . Periepididymal adipose tissue from obese CXCR3deficient mice contains fewer T cells than obese controls, as revealed by immunohistochemistry. Sections of periepididymal fat tissue from obese CXCR3-deficient mice and obese controls were stained for CD3, as described in the text (representative images are shown). Positive cells were counted under a microscope in 10 consecutive high-power fields. Data are shown as mean±SD. *P<0.01; n=3 to 4/group. July 2014 intraperitoneal glucose load than did control mice after 8 weeks of HFD (according to the area under the curve and all the individual time points on the curve) ( Figure 8A and 8C). Mice that consumed HFD for 16 weeks showed a similar trend, but the difference was not statistically significant; although there was a difference at baseline and at 20 minutes after glucose loading, all other time points on the glucose tolerance curve did not differ significantly between the groups, resulting in a nonsignificant difference between the areas under the curve ( Figure 8B and 8D) .
CXCR3-deficient mice had lower concentrations of plasma leptin than their obese wild-type counterparts after both 8 and 16 weeks of HFD ( Figure III in the online-only Data Supplement). Similarly, total plasma cholesterol levels, which increased over time in both groups of mice, were lower in CXCR3-deficient mice compared with controls ( Figure III 
Discussion
Despite the increasing recognition of the participation of T lymphocytes in the pathophysiology of obesity, the mechanism by which they accumulate in fat under obese conditions remains unclear. MCP-1 and RANTES, chemokines abundantly expressed in AT of obese mice, can induce migration of several cell types (including T lymphocytes) during inflammatory processes. Indeed, both of these chemokines seem to participate pivotally in macrophage accumulation in AT of obese mice and humans. 3, 9, 18 The finding that T-cell accumulation in AT of obese mice precedes the appearance of macrophages, 5,6 however, suggests the operation of a chemokine/receptor system with higher selectivity for T cells than that of RANTES/CCR5 or MCP1/ CCR2. Our results demonstrate that CXCR3 participates in T-cell accumulation in AT in the context of obesity. The exclusive ligation of CXCR3 with the T-cell chemoattractants IP-10, MIG, and IFN-inducible T-cell α chemoattractant, and its abundant expression in activated T cells, make this chemokine system an ideal candidate to initiate T-cell recruitment in AT of obese animals and, therefore, to orchestrate fat inflammation. Our data show a significant increase of CXCR3 mRNA levels in periepididymal AT-derived SVCs from obese C57BL6 mice compared with lean controls. Because CXCR3 expression associates with T-cell activation, this finding suggests that obesity enhances accumulation of activated T cells in AT.
CXCR3 deficiency in HFD-fed obese mice associated with significantly fewer CD3 + cells in periepididymal fat pads, represented by reduced numbers of both T lymphocyte subtypes-CD4 + and CD8 + cells. This reduction occurred at both early (8 weeks) and late (16 weeks) time points, with a more marked fall at 16 weeks. Therefore, despite the diversity and potential importance of other chemotactic pathways in fat inflammation, these results indicate a high degree of selectivity among them and support a crucial role of CXCR3 in the accumulation of T cells in AT of obese animals across time. Unlike T-cell numbers, macrophage and dendritic cell numbers were not lower in AT of obese CXCR3-deficient mice compared with controls. After 16 weeks of HFD, macrophages were more numerous in the fat of CXCR3-deficient mice relative to controls. This finding suggests that changes in specific T-cell subsets, such as the reduction of the Treg cellular pool in periepididymal fat of CXCR3-deficient mice compared with controls, impact the local number of macrophages later. Indeed, Treg cells can have suppressive effects on macrophages and T-effector cells. The similar numbers of T cells and other leukocyte populations in the spleen and blood of obese CXCR3deficient mice and control mice further support a local effect of CXCR3 on T-cell accumulation in AT of obese animals, independent of the circulating cell number.
T lymphocytes display functional heterogeneity, and different T-cell subsets can exert proinflammatory or anti-inflammatory actions on other lymphocyte subpopulations and other cells of the innate immune system. 19 CXCR3 deficiency in the context of obesity associated with reduction of the mRNA expression levels of RANTES (a product of cytotoxic T lymphocytes) and MCP-1, predominantly secreted by activated macrophages. Conversely, obese CXCR3-deficient mice also had decreased expression of IL-10 (a prototypical anti-inflammatory cytokine) and Foxp3 (a Treg marker). These results indicate that CXCR3 participates in the accumulation of various T-cell subsets and thus helps define the expression profiles of proinflammatory and anti-inflammatory molecules present in AT of obese mice. CXCR3 deficiency also reduces the expression of arginase-1, a marker of alternatively activated macrophages (M2) induced by Th2 cytokines such as IL-10, 20 typically involved in tissue repair and inflammation blockade. 21, 22 This finding suggests that the CXCR3/IP-10-MIG-ITAC chemokine system indirectly regulates macrophage function in AT of obese mice.
CXCR3 deficiency correlated with significant changes in several systemic metabolic variables. Obese CXCR3deficient mice had reduced levels of plasma leptin and cholesterol. In most atherosclerosis-susceptible mouse strains (eg, C57BL/6), plasma high-density lipoprotein cholesterol levels decrease and total cholesterol levels increase substantially after initiating an HFD. The majority of the increase in plasma cholesterol derives from increase of very-low-density lipoprotein and low-density lipoprotein fractions. 23, 24 But, considering that in normal mice the high-density lipoprotein fraction carries most of cholesterol and that high-density lipoprotein cholesterol levels fall under HFD, we cannot exclude a contribution of high-density lipoprotein cholesterol decrease among the CXCR3-deficient mice to our findings. Obese CXCR3-deficient mice also had greater glucose tolerance than their obese wild-type counterparts after 8 weeks of HFD. But differences in glucose tolerance curves between the 2 groups became nonsignificant after 16 weeks of HFD, coinciding with a substantial fall in the expression of anti-inflammatory markers-including IL-10 (also significantly decreased after 8 weeks of HFD), arginase-1, and Foxp3-in the fat tissue of CXCR3-deficient mice compared with controls. In agreement with this finding, the AT of CXCR3-deficient mice had significantly fewer Foxp3-positive cells than did that of controls, as determined by immunohistochemical analysis, suggesting that CXCR3 plays a role in Treg accumulation in AT. Several studies have shown that reduced numbers of antiinflammatory cells (such as M2 macrophages and Tregs) and their products in AT associate with deterioration of metabolic homeostasis. 25, 26 Feuerer et al 25 demonstrated that AT of obese mice contains fewer Tregs than AT of lean mice, and this diminished pool of cells may cause excessive inflammation and its metabolic consequences in obesity. Moreover, treatment with a CD3-specific antibody reduced the predominance of Th1 cells over Foxp3 cells in obese mice, reversing insulin resistance. 27 Our findings suggest that CXCR3 deficiency interferes with the accumulation of distinct T-cell subsets with antagonistic functions, and temporal changes in the size of distinct T-cell pools may alter the balance of expression of proinflammatory and anti-inflammatory molecules. The net effect of this duality between proinflammatory and anti-inflammatory forces within the AT likely impacts local and systemic metabolism. In our study, reduced numbers of effector T cells in the AT of CXCR3-deficient mice may have prevailed at 8 weeks of HFD, eliciting improved glucose tolerance, whereas a reduced number of anti-inflammatory T cells may have compensated the effect at 16 weeks of HFD, abrogating the improvement in glucose tolerance.
Our study has limitations. We have not analyzed the impact of CXCR3 deficiency on fat depots beyond the periepididymal AT. Despite the clear importance of this fat pad in mice as an inflammatory source in the context of obesity, the present results do not discount potential contributions of other AT depots. Accumulating evidence supports a differential role of distinct fat depots in a range of systemic or local effects. 28 Whereas fat storage in the visceral area associates with increased local and systemic inflammation and higher cardiometabolic risk in humans, accumulation of fat in lower-body subcutaneous AT likely has less adverse metabolic consequences. Moreover, accumulation of fat in AT depots around or near organs, such as perivascular or pericardial fat, likely affects primarily the adjacent tissue through lipotoxicity and secretion of inflammatory mediators.
Another unanswered question regards the origin of AT inflammation in fat-fed mice-obesity or the HFD itself. Data from this article and from previous feeding investigations do not isolate the excess adiposity from the HFD itself as the driver of AT inflammation in diet-induced obese mice, another limitation inherent in the design of such studies.
Conclusions
This study demonstrates an important role of CXCR3 in T-cell accumulation in periepididymal AT of obese mice, with a significant metabolic impact. Our results suggest that CXCR3 may regulate the accumulation of distinct subsets of T cellsthe relative proportions of which, across time, likely influence local and systemic metabolism. Understanding the roles of both the innate and adaptive immune arms in the pathophysiology of obesity may pave the road toward novel therapeutic alternatives against this condition. 
